Search

everythinglearnresearchcommunity

for

Search:↓

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

A man developed a rare skin condition and drug-induced lupus, highlighting the need for biopsy in diagnosing skin issues caused by sunlight.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

A child with a rare scalp condition regrew hair after treatment.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Neuropsychiatric lupus is a severe form of lupus that needs strong treatment to improve life quality.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Oral ulcers are common in SLE patients and often link to other symptoms.